DETECTION AND ANALYSIS OF H-2 VARIANT CELL LINES FROM MURINE T CELL LYMPHOMAS
DETECTION AND ANALYSIS OF H-2 VARIANT CELL LINES FROM MURINE T CELL LYMPHOMAS
批准号:
4691769
负责人:
G M SHEARER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
BALB/c起源的S-49 T细胞淋巴瘤的各种细胞系正在研究中。
研究H-2抗原的表达。 正常BALB/c淋巴细胞
表达H-2Kd、H-2Dd和H-2Dd抗原。 我们发现,
目前研究的S-49淋巴瘤细胞系并不表达所有这些细胞
表面H-2抗原。 H-2抗原的表达模式,
这些细胞作为(a)抗体和补体;和(B)细胞毒性的靶
T淋巴细胞(CTL)在T细胞中表现出四种不同的H-2d表达模式,
测试的五条线路。 这一系统对今后的研究具有一定的参考价值
主要组织相容性复合体(MHC)表达的调节
抗原,并提高了相对较高的感染率的可能性
这些抗原在相同来源的肿瘤细胞系之间的调节。
过去一年,该项目没有取得任何进展。
英文摘要
Various lines of the S-49 T cell lymphoma of BALB/c origin are being
studies for the expression of H-2 antigens. Normal BALB/c lymphocytes
express H-2Kd, H-2Dd, and H-2Dd antigens. We have found that the five
lines of the S-49 lymphoma thusfar studied do not express all of these cell
surface H-2 antigens. The patterns of expression of H-2 antigens using
these cells as targets for: (a) antibody and complement; and (b) cytotoxic
T lymphocytes (CTL) exhibit four different patterns of H-2d expression in
the five lines tested. This system may be of value for investigating
regulation of expression of major histocompatibility complex (MHC)
antigens, and raises the possibility of a relatively high rate of
modulation of these antigens among tumor cell lines of the same origin.
No progress was made in this project during the past year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CELLULAR IMMUNE FUNCTION IN AIDS AND CANCER
-
批准号:6100958
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
CELL MEDIATED IMMUNITY TO HAPTEN MODIFIED SYNGENEIC LYMPHOCYTES IN MICE
-
批准号:4691755
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
-
批准号:3962949
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
IMMUNE STUDIES IN HOMOSEXUAL MEN AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME
-
批准号:3939243
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
-
批准号:3916407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
MURINE AND HUMAN AUTOIMMUNITY
-
批准号:2463771
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
EFFECTS OF GRAFT VS HOST REACTIONS ON CELL-MEDIATED IMMUNITY
-
批准号:3813460
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
IMMUNE STUDIES IN HOMOSEXUAL MEN AT RISK FOR ACQUIRED IMMUNE DEFICIENCY SYNDROME
-
批准号:3962956
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
MURINE AND HUMAN AUTOIMMUNITY
-
批准号:6161062
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
T CELL IMMUNE DYSREGULATION IN CANCER
-
批准号:3774434
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
REGULATION OF HUMAN T CELL RESPONSES BY ADHERENT CELLS
-
批准号:3939372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
CELLULAR IMMUNE FUNCTION IN AIDS AND IN PRIMARY IMMUNE DEFICIENCIES
-
批准号:3752096
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
CELLULAR IMMUNE FUNCTION IN AIDS AND IN PRIMARY IMMUNE DEFICIENCIES
-
批准号:3774393
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
STUDIES OF T LYMPHOCYTE FUNCTION IN TRANSPLANTATION
-
批准号:3808597
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
-
批准号:3813461
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
T CELL IMMUNE DEFICIENCY IN MICE AND HUMANS WITH AUTOIMMUNE DISEASE
-
批准号:3813474
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
SYNERGISTIC EFFECTS OF MURINE CYTOMEGALOVIRUS AND GRAFT-VERSUS-HOST REACTION
-
批准号:3939237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
DETECTION AND ANALYSIS OF H-2 VARIANT CELL LINES FROM MURINE T CELL LYMPHOMAS
-
批准号:3962952
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
CELLULAR IMMUNE FUNCTION IN AIDS AND IN PRIMARY IMMUNE DEFICIENCIES
-
批准号:5201011
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
T CELL IMMUNE DYSREGULATION IN CANCER
-
批准号:3752141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G M SHEARER
-
依托单位:
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘宇佳
-
依托单位: